Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own

The annual ICT4D Conferences have proven to be an invaluable opportunity for NGOs, private sector organizations, universities, governmental agencies and foundations to share their experience in using ICT to increase the impact of development programs and to learn from each other.  In 2016, 750 individuals from 76 countries and 320 private sector and public sector and civil society explored the ways to harness the full power of digital solutions to achieve the United Nations’ Sustainable Development Goals.  Our thanks to Accenture, Catholic Relief Services, Esri, Hewlett Packard Enterprise, iMerit Technology Services, Inmarsat, IS Solutions, Making All Voices Count, Mercy Corps, Microsoft, NetHope, Oxfam, Pandexio, Qualcom Wireless Reach, RTI International, SimbaNet and World Vision for making that possible.

View analytic
Thursday, May 19 • 12:15 - 13:00
Effects of a Mobile Phone Short Message Service on Antiretroviral Treatment Adherence in Kenya (WelTel Kenya1): A Randomized Trial LIMITED

Log in to save this to your schedule and see who's attending!

Limited Capacity seats available

Mobile phone communication may improve delivery of health services. However, data on the effects of mobile health technology on patient outcomes in resource-limited settings are limited. We aimed to assess whether mobile phone communication between health-care workers and patients starting antiretroviral therapy in Kenya improved drug adherence and suppression of plasma HIV-1 RNA load.
Methods: WelTel Kenya1 was a multisite randomized clinical trial of HIV-infected adults initiating antiretroviral therapy (ART) in three clinics in Kenya. Patients were randomized (1:1) to a mobile phone short message service (SMS) intervention or standard care. Patients in the intervention group received weekly SMS messages from a clinic nurse and were required to respond within 48h. Primary outcomes were self-reported ART adherence (> 95% of prescribed doses in the past 30 days at both 6 and 12 month follow-up visits) and plasma HIV-1 viral RNA load suppression 

Speakers
avatar for Bonface Beti

Bonface Beti

Senior Advocacy and Policy Advisor, Weltel International mHealth Society
Bonface joined the Weltel team in June 2009 when it started as a CDC-PEPFAR HIV Trial research at the University of Manitoba working as a senior advocacy manager. Prior to this, Bonface had worked with the World Social Forum Secretariat as an international Media Coordinator and at UNICEF Kenya as Communication Officer in Health Projects. Currently Bonface is working with WelTel scaling-up programmes as a Senior Policy Advocacy Advisor in Nairobi... Read More →


Thursday May 19, 2016 12:15 - 13:00
Giraffe 257

Attendees (3)